Search results
Immunotherapy drug may keep colon cancer patients cancer-free after surgery
UPI· 18 hours agoDoctors in Britain say that an immunotherapy drug, given before surgery, can help many more colon...
Experimental mRNA vaccines gain steam with promising cancer trial results
Semafor via Yahoo News· 17 hours agoMelanoma patients who received monthly mRNA vaccines and Merck’sKeytruda immunotherapy had lower...
... 3-Year Data For mRNA-4157 (V940) in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated...
Digital Journal· 1 day agoAt a median planned follow-up of the Phase 2b study at 34.9 months, mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 49% and the risk ...
Merck's Multi-Billion Cancer Drug Keytruda Aces Late-Stage Breast Cancer Study (UPDATED)
Benzinga via Yahoo Finance· 7 days agoTuesday, Merck & Co Inc (NYSE:MRK) released topline data from hase 3 KEYNOTE-522 trial of Keytruda...
Merck’s KEYTRUDA shows survival benefits in Phase III TNBC trial
Clinical Trials Arena via Yahoo Finance· 6 days agoKEYTRUDA’s safety profile aligned with previous studies, showing no new safety concerns. In the US, ...
Merck to buy eye-focused drug developer EyeBio for as much as $3 billion By Reuters
Investing.com· 6 days agoMerck said in February it was in the market for deals of up to $15 billion, and has already struck...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 23 hours agoModerna and Merck released more positive three-year data Monday on their experimental vaccine, given...
An mRNA Melanoma Vaccine Shows Promise
Time Magazine· 1 day agoThe company presented the latest results from its trial involving 157 people with advanced skin cancer at the annual meeting of the American Society of...
Merck nears $1.3 billion cash deal for eye-drug company EyeBio, WSJ reports
Reuters via Yahoo Finance· 6 days agoMerck has said it's in the market for deals of up to around $15 billion as it plans ways to deal...
Experimental Therapy Shows Promise in Pancreatic C | Newswise
Newswise· 5 days agoImmunotherapy drugs alone have not shown to be responsive to pancreatic cancer. The findings were presented at the American Society of Clinical Oncology 2024 annual meeting ...
